BRAINSTORM CELL THERAPEUTICS INC. — Form D

BRAINSTORM CELL THERAPEUTICS INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2014-05-09. The offering totals $2.5M, of which $1.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Mordechai FriedmanDirectorNEW YORK, NY
Irit ArbelDirectorJERUSALEM, L3
Chen SchorDirectorNEW YORK, NY
Ralph KernExecutive OfficerNEW YORK, NY
Dr. Anthony PolverinoDirectorNEW YORK, NY
Arturo ArayaDirectorNEW YORK, NY
Arturo ArayaExecutive OfficerNEW YORK, NY
Dr. June AlmenoffDirectorNEW YORK, NY
Dr. Irit ArbelDirectorNEW YORK, NY
Malcolm TaubDirectorNEW YORK, NY
Chaim LebovitsExecutive OfficerNEW YORK, NY
Eyal RubinExecutive OfficerTEL AVIV, L3
Uri YablonkaDirectorNEW YORK, NY
Uri YablonkaExecutive OfficerNEW YORK, NY
Mordechai S FriedmanDirectorHackensack, NJ
Anthony S FiorinoExecutive OfficerHackensack, NJ
Alon PinkasDirectorNEW YORK, NY
Uri S YablonkaDirectorHackensack, NJ
Uri S YablonkaExecutive OfficerHackensack, NJ
Liat SossoverExecutive OfficerNEW YORK, NY
Chaim S LebovitsExecutive OfficerHackensack, NJ
Robert ShorrDirectorNEW YORK, NY
Malcolm S TaubDirectorHackensack, NJ
Adrian S. HarelExecutive OfficerNEW YORK, NY
Mordechai S. FriedmanDirectorNEW YORK, NY

Other filings by this issuer (5)

FiledFormOfferingSold
2019-08-09D
2018-06-20D
2015-01-21D
2014-07-01D$10.5M$10.5M
2012-07-27D$207K$207K

More